SIRPG | OmnibusX

Name	Number of supported studies	Average coverage
regulatory T cell	17 studies	34% ± 13%	Explore
CD8-positive, alpha-beta T cell	10 studies	33% ± 12%	Explore
CD4-positive, alpha-beta T cell	9 studies	27% ± 10%	Explore
T cell	8 studies	22% ± 6%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	7 studies	20% ± 4%	Explore
T follicular helper cell	7 studies	24% ± 9%	Explore
mucosal invariant T cell	6 studies	19% ± 3%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	22% ± 8%	Explore
CD8-positive, alpha-beta memory T cell	5 studies	23% ± 8%	Explore
gamma-delta T cell	5 studies	29% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	19% ± 4%	Explore
exhausted T cell	4 studies	41% ± 14%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	23% ± 5%	Explore
intraepithelial lymphocyte	3 studies	25% ± 6%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	28% ± 3%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	19% ± 4%	Explore

sc-RNAseq data

Insufficient scRNA-seq data for expression of SIRPG at tissue level.

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	93%	64.86	538 / 578	74%	5.12	854 / 1155
stomach	70%	35.81	253 / 359	61%	4.35	175 / 286
intestine	60%	156.61	579 / 966	56%	3.29	293 / 527
prostate	78%	47.08	192 / 245	29%	1.29	147 / 502
bladder	57%	44.43	12 / 21	50%	3.23	252 / 504
thymus	64%	69.16	416 / 653	43%	6.14	258 / 605
kidney	48%	30.98	43 / 89	53%	4.42	475 / 901
lymph node	0%	0	0 / 0	100%	44.05	29 / 29
spleen	100%	682.44	241 / 241	0%	0	0 / 0
uterus	41%	11.89	69 / 170	57%	4.51	261 / 459
esophagus	35%	18.07	501 / 1445	55%	3.28	100 / 183
breast	38%	14.24	176 / 459	51%	3.75	569 / 1118
tonsil	0%	0	0 / 0	89%	12.74	40 / 45
liver	62%	19.91	141 / 226	25%	1.93	100 / 406
peripheral blood	86%	349.19	797 / 929	0%	0	0 / 0
skin	20%	5.28	353 / 1809	62%	9.43	291 / 472
pancreas	9%	2.46	30 / 328	54%	3.48	96 / 178
adipose	55%	21.49	666 / 1204	0%	0	0 / 0
ovary	11%	3.60	19 / 180	33%	1.43	140 / 430
adrenal gland	35%	10.68	91 / 258	3%	0.16	8 / 230
blood vessel	27%	12.87	356 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	18%	1.68	14 / 80
brain	9%	1.99	250 / 2642	2%	0.13	17 / 705
heart	10%	2.95	84 / 861	0%	0	0 / 0
muscle	1%	0.30	7 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

GO_0022409	Biological process	positive regulation of cell-cell adhesion
GO_0008284	Biological process	positive regulation of cell population proliferation
GO_0050870	Biological process	positive regulation of T cell activation
GO_0008285	Biological process	negative regulation of cell population proliferation
GO_0050766	Biological process	positive regulation of phagocytosis
GO_0035556	Biological process	intracellular signal transduction
GO_0007155	Biological process	cell adhesion
GO_0007267	Biological process	cell-cell signaling
GO_0005886	Cellular component	plasma membrane
GO_0016020	Cellular component	membrane
GO_0005515	Molecular function	protein binding

Gene name	SIRPG
Protein name	Signal-regulatory protein gamma (SIRP-gamma) (CD172 antigen-like family member B) (Signal-regulatory protein beta-2) (SIRP-b2) (SIRP-beta-2) (CD antigen CD172g)
Synonyms	SIRPB2
Description	FUNCTION: Probable immunoglobulin-like cell surface receptor. On binding with CD47, mediates cell-cell adhesion. Engagement on T-cells by CD47 on antigen-presenting cells results in enhanced antigen-specific T-cell proliferation and costimulates T-cell activation. .
Accessions	ENST00000381580.5 [Q9P1W8-2] Q9P1W8 ENST00000303415.7 [Q9P1W8-1] ENST00000381583.6 [Q9P1W8-4] ENST00000216927.4 [Q9P1W8-4] ENST00000344103.8 [Q9P1W8-3]

SIRPG report